FDA Approves Label Change For Non-Invasive Fibroid Treatment - Allows Doctors To Use ExAblate(R) To Treat Up To 100% ... (Medical News Today)
InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate(R) 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.

FDA Approves Label Change For Non-Invasive Fibroid Treatment (Medical News Today)
InSightec Ltd. announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate(R) 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.

Core Essence Receives FDA Approval For SECURUS(TM), An Innovative Knotless Suture Anchor System (Medical News Today)
Core Essence Orthopaedics, Inc., a medical device company focused on soft tissue and skeletal repair of the extremities, announced that it has received 510(k) regulatory approval from the Food and Drug Administration (FDA) for SECURUS(TM), a novel knotless suture anchor system used in minimally invasive, arthroscopic surgery.